carbamates has been researched along with Carcinoma, Bronchial in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| VELASCO, HA | 1 |
| ROSS, CA | 1 |
| WEBSTER, JH | 1 |
| SOKAL, JE | 1 |
| STUTZMAN, L | 1 |
| AMBRUS, JL | 2 |
| MECHL, Z | 1 |
| KOLAR, V | 1 |
| KONECNY, M | 1 |
| Gailani, S | 1 |
| Blais, M | 1 |
| Bardos, TJ | 1 |
| Ambrus, CM | 1 |
1 trial available for carbamates and Carcinoma, Bronchial
| Article | Year |
|---|---|
Clinical trial of acetylenic carbamate: 1,1-diphenyl-2-propynyl cyclohexanecarbamate (NSC-112682).
Topics: Adolescent; Adult; Aged; Alkynes; Antineoplastic Agents; Carbamates; Carcinoma, Bronchogenic; Carcin | 1970 |
3 other studies available for carbamates and Carcinoma, Bronchial
| Article | Year |
|---|---|
COMBINED USE OF AB-132 (METUREDEPA, TURLOC) AND X-IRRADIATION IN THE MANAGEMENT OF ADVANCED BRONCHOGENIC CARCINOMA.
Topics: Alkylating Agents; Antineoplastic Agents; Aziridines; Biomedical Research; Carbamates; Carcinoma, Br | 1964 |
THE USE OF THE DRUGS AB 103 AND AB 132 IN THE COMBINED TREATMENT OF TUMOURS OF THE CERVICAL AND PULMONARY REGIONS.
Topics: Alkylating Agents; Antineoplastic Agents; Aziridines; Carbamates; Carcinoma, Bronchogenic; Carcinoma | 1964 |
Combination of chemotherapy with dual antagonists and radiotherapy in the treatment of neoplastic disease.
Topics: Alkylating Agents; Antimetabolites; Antineoplastic Agents; Azirines; Carbamates; Carcinoma, Bronchog | 1971 |